Inspection Record

Distrivet Inc. — Health Canada Inspection Findings

Health CanadaInspected 2022-11-22 5 findingsEquipment and facilityOther quality systemTraining and personnelStability and storage

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

2Other quality system

The retention time for records was inadequate.

3Training and personnel

The effectiveness of the training was not assessed by the firm. The ongoing training of personnel was inadequate.

4Equipment and facility

Evaluation of production processes, equipment, and/or materials was inadequate.

5Stability and storage

The evidence used to demonstrate the transportation and/or storage conditions of each lot or batch of the drug was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-11-22. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Distrivet Inc. company profile — full history Health Canada documents, 2022 Go to Findings search